Altimmune (ALT) Change in Receivables (2010 - 2026)
Altimmune's (ALT) quarterly Change in Receivables came in at $446000.0 in Q1 2026, up 1305.41% year-on-year from $31734.6 in Q1 2025, and up 19.25% on a QoQ basis from $374000.0 in Q4 2025.
Altimmune (ALT) Change in Receivables (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Change in Receivables data on file, last reported at $446000.0 in Q1 2026.
- On a quarterly basis, Change in Receivables rose 1305.41% year-over-year to $446000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 479.0% increase from a year earlier, with the FY2025 full-year figure at $675000.0, up 219.05% from the prior year.
- Change in Receivables for Q1 2026 stood at $446000.0, up from $374000.0 in the prior quarter.
- Over the last five years, Change in Receivables for ALT reached as high as $741000.0 in Q3 2023 and fell as low as -$804000.0 in Q1 2024.
- Historically, Change in Receivables has averaged $72705.9 across 5 years, with a median of $80000.0 in 2023.
- Across the five-year window, Change in Receivables slumped 4000.0% in 2023 and jumped 13000.0% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$460000.0 in 2022, then soared by 150.87% to $234000.0 in 2023, then plunged by 50.43% to $116000.0 in 2024, then soared by 222.41% to $374000.0 in 2025, then advanced by 19.25% to $446000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $446000.0 in Q1 2026, $374000.0 in Q4 2025, and $524000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | 446,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 524,000.00 |
| Sep 30, 2025 | 524,000.00 |
| Jun 30, 2025 | -186,000.00 |
| Jun 30, 2025 | -186,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 117,000.00 |
| Mar 31, 2024 | -804,000.00 |
| Mar 31, 2024 | -804,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Dec 31, 2023 | 234,000.00 |